Abstract A four year old boy with pulmonary atresia and ventricular septal defect had an acute cyanotic episode three years after undergoing a right-sided, 6 mm diameter, modified Blalock-Taussig shunt. On admission no continuous murmur could be heard from the shunt and the typical high velocity, continuous flow profile of the shunt could not be identified by Doppler echocardiography. At catheterisation a right subclavian artery angiogram confirmed shunt occlusion. From the subclavian artery, an 0 035 inch wire was used to enter the occluded shunt and then the pulmonary artery. Balloon angioplasty of the entire length of the shunt was performed with 6 mm diameter balloon. After angioplasty the arterial oxygen saturation increased from 63% to 83%. The patient was treated with intravenous heparin followed by warfarin. Repeat catheterisation and angiography eight days later confirmed wide patency of the shunt. Modified Blalock-Taussig shunts with interposition tube grafts between the subclavian artery and pulmonary artery are standard palliative treatment for various cyanotic congenital heart defects.' A major complication is shunt occlusion, which often requires emergency surgical revision.2 Transcatheter balloon dilatation of both occluded peripheral arteries and of stenosed (but not occluded) Blalock-Taussig shunts have been described previously. We describe successful recanalisation of an occluded modified Blalock-Taussig shunt in a child.
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Case report A four year old boy presented shortly after birth with moderate central cyanosis. A diagnosis of pulmonary atresia with ventricular septal defect, confluent central pulmonary arteries, and multiple aortopulmonary collateral vessels was based on echocardiography and cardiac catheterisation. At the age of 12 months he underwent a right-sided modified Blalock-Taussig shunt (6 mm Gore-tex graft), after which he was treated with oral aspirin and dipyridamole at standard doses. He presented to his local hospital three years later with acute onset of cyanosis, associated with absence of a continuous murmur from the shunt. He was referred to our hospital.
At admission he had severe cyanosis with a systemic arterial oxygen saturation of 63%. Doppler echocardiography did not show the continuous high velocity flow profile associated with the shunt. His parents gave informed consent and cardiac catheterisation was performed the next day. A retrograde femoral arterial approach was used to obtain a right subclavian artery angiogram with a 5F Cobra (Cordis) catheter. This confirmed complete occlusion of the shunt (fig 1) hospital 12 days later. Before discharge, repeat cardiac catheterisation and angiography confirmed that the shunt was patent. 
Discussion

